Bloomage BioTechnology Corporation Limited (SHA: 688363)

China flag China · Delayed Price · Currency is CNY
48.72
-0.48 (-0.98%)
Sep 6, 2024, 3:00 PM CST
-47.04%
Market Cap 23.32B
Revenue (ttm) 5.81B
Net Income (ttm) 509.71M
Shares Out 478.64M
EPS (ttm) 1.06
PE Ratio 45.99
Forward PE 28.63
Dividend 0.38 (0.78%)
Ex-Dividend Date Aug 8, 2024
Volume 681,944
Open 49.00
Previous Close 49.20
Day's Range 48.72 - 49.39
52-Week Range 47.95 - 91.50
Beta 0.71
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Bloomage BioTechnology Corporation

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th... [Read more]

Sector Materials
Founded 2000
Employees 4,655
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688363
Full Company Profile

Financial Performance

In 2023, 688363's revenue was 6.08 billion, a decrease of -4.45% compared to the previous year's 6.36 billion. Earnings were 592.56 million, a decrease of -38.97%.

Financial Statements

News

There is no news available yet.